Cytokinetics (CYTK) had the highest return in December 2014 by a large-cap US stock, returning 72.3%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Cytokinetics (CYTK) | December 2014 | 72.26% |
QXO (QXO) | December 2014 | 29.41% |
Arrowhead Pharmaceuticals (ARWR) | December 2014 | 28.13% |
IAMGold (IAG) | December 2014 | 26.76% |
MACOM Technology Solutions (MTSI) | December 2014 | 25.88% |
Axon Enterprise (AXON) | December 2014 | 24.03% |
Coeur Mining (CDE) | December 2014 | 21.67% |
First Majestic Silver (AG) | December 2014 | 19.81% |
Ionis Pharmaceuticals (IONS) | December 2014 | 19.65% |
Comfort Systems USA (FIX) | December 2014 | 18.72% |
Restaurant Brands International (QSR) | December 2014 | 18.37% |
Ciena (CIEN) | December 2014 | 17.57% |
Advanced Energy Industries (AEIS) | December 2014 | 16.69% |
Genmab A-S (GMAB) | December 2014 | 16.55% |
Hecla Mining (HL) | December 2014 | 16.25% |
Lululemon Athletica (LULU) | December 2014 | 15.77% |
Hudbay Minerals (HBM) | December 2014 | 15.58% |
SS&C Technologies (SSNC) | December 2014 | 15.5% |
Heico (HEI) | December 2014 | 14.22% |
Dycom Industries (DY) | December 2014 | 14.15% |
Onto Innovation (ONTO) | December 2014 | 13.34% |
Ensign (ENSG) | December 2014 | 13.08% |
Ryanair Holdings PLC ADR (RYAAY) | December 2014 | 12.7% |
TTM Technologies (TTMI) | December 2014 | 12.56% |
Neurocrine Biosciences (NBIX) | December 2014 | 12.26% |
Large-cap stocks are treated as having a market cap of $10B+.